Received Apr 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | X025482 | — |
No additional adverse event; expired dose of VAQTA was administered to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-APR-2025, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) first dose, (exact dose administered, anatomical route of administration were not reported) (lot #X025482, who had been verified to be a valid lot number and expiration date reported and validated as 12-APR-2025) as prophylaxis (expired product administered). No additional adverse event.